Rehospitalization rates, costs, and risk factors for inflammatory bowel disease: a 16-year nationwide study

Data de publicação:

Autores da FMUP

  • Fernando José Magro Dias

    Autor

  • Claudia Camila Rodrigues Pereira Dias

    Autor

Participantes de fora da FMUP

  • Santiago, M
  • Correia, L
  • Portela, F
  • Ministro, P
  • Lago, P
  • Trindade, E
  • Portuguese IBD Study Grp GEDII

Unidades de investigação

Abstract

Aims: We aimed to describe the burden of rehospitalization in patients with inflammatory bowel disease (IBD), by evaluating rehospitalization rates, charges, and risk factors over 16 years. Methods: We performed a retrospective analysis of all hospital discharges with a primary diagnosis of IBD in public hospitals between 2000 and 2015 in mainland Portugal from the Central Administration of the Health System (ACSS)'s national registry. We collected data on patient, clinical, and healthcare charges. We used survival analysis to estimate the rate and risk factors of IBD-related rehospitalization. Results: We found that 33% (n = 15,931) of the IBD-related hospitalizations corresponded to rehospitalizations, which increased by 12% over 16 years. However, IBD rehospitalization rate per 100,000 IBD patients decreased 2.5-fold between 2003 and 2015. Mean IBD-related rehospitalization charges were euro14,589/hospitalization-year in 2000 and euro17,548 /hospitalization-year in 2015, with total rehospitalization charges reaching euro3.1 million/year by 2015. Overall, the 30-day rate of rehospitalization was 24% for Crohn's disease (CD) and 22.4% for ulcerative colitis (UC). Novel risk factors for rehospitalization include penetrating disease in CD patients {hazard ratio (HR) 1.34 [95% confidence interval (CI) 1.20-1.51], p < 0.001} and colostomy in UC patients [HR 2.84 (95% CI 1.06-7.58)]. Conclusion: IBD-related rehospitalization should be closely monitored, and efforts to reduce its risk factors should be made to improve the quality of care and, consequently, to reduce the burden of IBD.

Dados da publicação

ISSN/ISSNe:
1756-283X, 1756-2848

Therapeutic Advances in Gastroenterology  SAGE Publications Ltd

Tipo:
Article
Páginas:
-
Link para outro recurso:
www.scopus.com

Citações Recebidas na Scopus: 1

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • burden; Crohn's disease; hospitalization; inflammatory bowel diseases; patient discharge; Portugal; registries; risk factors; ulcerative colitis

Financiamento

Proyectos asociados

Contributo da endoscopia, biomarcadores e imagiologia na evolução clinica dos doentes com doença inflamatória intestinal

Investigador Principal: Fernando José Magro Dias

Estudo Clínico Académico . 2019

Citar a publicação

Partilhar a publicação